Novartis Gene Therapies, Inc.
EIR issued February 15, 2019 · San Diego, California
- Inspection
- Feb 13 – Feb 15, 2019
- Investigators
- Andrew Byrnes· Burnell M. Henry
- Pages
- 14
- FEI number
- 3014617030
In short: This is FDA's Establishment Inspection Report (EIR) for Novartis Gene Therapies, Inc. in San Diego, California (FEI 3014617030), covering the inspection of Feb 13 – Feb 15, 2019. It is the investigator's full narrative of what they examined, who they spoke to and what they found. The investigators were Andrew Byrnes and Burnell M. Henry.
Inside this inspection report
The investigator's narrative
The full inspection report: what the investigator looked at, who they spoke to and what they found, in their own words.
Get the full EIRThis inspection in context
Andrew Byrnes
2 documents · 2019–2020
Cites 211.192 (production record review) more than any other section. Most of their documents are for sites in California.
The firmNovartis Gene Therapies, Inc. history
All 5 documents on file for this site, in date order, with what was cited at each inspection.
Similar documentsMore eirs
Browse other documents of this type.
Questions about this EIR
Who inspected Novartis Gene Therapies, Inc.?
Andrew Byrnes and Burnell M. Henry are named on this EIR, for the inspection of Feb 13 – Feb 15, 2019. Each investigator has a profile showing what they cite most.
When was Novartis Gene Therapies, Inc. inspected by FDA?
The inspection ran Feb 13 – Feb 15, 2019.
How do I get the full EIR for Novartis Gene Therapies, Inc.?
Download the original PDF from FDA Intel for $550, with no subscription. You also get an invoice PDF with the order.